Adjuvant-induced arthritis model

MB Marc Bigaud
ZD Zuhal Dincer
BB Birgit Bollbuck
JD Janet Dawson
NB Nicolau Beckmann
CB Christian Beerli
GF Gina Fishli-Cavelti
MN Michaela Nahler
DA Daniela Angst
PJ Philipp Janser
HO Heike Otto
ER Elisabeth Rosner
RH Rene Hersperger
CB Christian Bruns
JQ Jean Quancard
request Request a Protocol
ask Ask a question
Favorite

Wistar rats (male, 220–250 g, Charles River-Germany) were injected intradermally at the base of the tail (100μl) with complete Freunds adjuvant containing M. tuberculosis. In this model, arthritis develops in approximately 11–12 days after injection with the adjuvant, as revealed by a severe swelling of the hind paws [24]. The rats were treated orally with FTY720 at 0.1 mg/kg QD, NIBR-0213 at 30 mg/kg BID, or its vehicle at day-5 or day-9 post-injection of complete Freund’s adjuvant, but before the onset of arthritis (n = 5–10/group). To assess the development of arthritis in each animal, the diameters of both hind paws were measured, in the medial-lateral and anterior-posterior directions, to calculate a mean paw diameter (mØ) at baseline and at termination and evaluate paw swelling as the difference between both values (ΔmØ). The inhibitory effects of NIBR-0213 treatments were expressed as % inhibition vs swelling in vehicle-treated group.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A